Welcome to this week’s edition of 18 Share Tips: our weekly selection of top ASX shares, chosen by leading analysts, that we think are worth considering.
This week Stuart Bromley of Medallion Financial Group, Blake Halligan of Gray Perry Wealth Advisers, and Mark Elzayed of Vestra Capital share their ‘Buy’, ‘Hold’ and ‘Sell’ recommendations.
Please note these share tips are simply recommendations and are in no way intended as financial advice. These share tips are general advice and don’t take into account any individual’s financial situation. Investors are advised to seek professional financial advice before investing.
Stuart Bromley, Medallion Financial Group
BUY RECOMMENDATIONS
BUY – Pro Medicus (PME)
Pro Medicus is a global leader in medical imaging software, with its Visage platform increasingly adopted by major US hospital networks. Revenue of $261.7 million in full year 2026 rose 22.9 per cent on the prior corresponding period. Underlying net profit after tax of $144.7 million was up 24.1 per cent. Revenue and underlying net profit exceeded expectations, while the underlying earnings before interest and tax margin reached an exceptional 74.9 per cent. It signed 10 new contacts worth $407 million in full year 2026. It renewed six contracts on five year terms to the value of $141 million. Recent share price weakness provides an attractive entry point into a high quality growth businesses.
BUY – Saluda Medical, Inc. (SLD)
Saluda makes the Evoke spinal cord stimulator, which automatically adjusts pain therapy in real time. Results in full year 2026 were strong, in our view. Revenue of $US90.2 million was up 28 per cent on the prior corresponding period and ahead of upgraded guidance. US patient implants increased by 50 per cent in the fourth quarter of 2026. With its newly approved CAP24 surgical paddle lead expanding the addressable US market by about 30 per cent, we believe SLD presents as an attractive buying opportunity for investors comfortable with potential share price volatility and risk.
HOLD RECOMMENDATIONS
HOLD – Generation Development Group (GDG)
GDG operates a portfolio of growing financial services businesses, including Generation Life, Evidentia Group and Lonsec. Total revenue of $178.7 million in full year 2026 was up 23 per cent on the prior corresponding period. Underlying net profit after tax of $40.7 million grew 21 per cent, supported by growth of 37 per cent in funds under management and record group net inflows of $9.7 billion. We believe GDG’s longer term growth opportunity remains intact.
HOLD – PolyNovo (PNV)
The company provides dermal regeneration solutions via its NovoSorb biodegradable polymer technology. Total revenue of $150 million in full year 2026 was up 16.1 per cent on the prior corresponding period. EBITDA of $12.1 million was up 8.1 per cent. While growth has moderated from earlier years, the longer-term opportunity remains significant as PolyNovo expands geographically and broadens adoption across burns, trauma and complex wounds.
SELL RECOMMENDATIONS
SELL – Flight Centre Travel Group (FLT)
The global travel agency group delivered record total transaction volumes in full year 2026. However, underlying profit before tax of $278 million declined by 4 per cent as Middle East disruption weighed heavily on the leisure business. We view geopolitical uncertainty, airline capacity constraints and softer consumer conditions as headwinds. We see better risk-adjusted opportunities elsewhere.
SELL – Commonwealth Bank of Australia (CBA)
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - market-leading social trading platform - Read our review
CBA remains Australia’s highest quality major bank. The company posted cash net profit after tax of $10.982 billion in full year 2026, up 7 per cent on the prior corresponding period. The full year dividend of $5.05, fully franked, is up 4 per cent. Despite the strong result, we believe the valuation is stretched, particularly as higher interest rates weigh on housing activity and credit growth. CBA shares were recently trading at historically elevated valuations compared to global peers. Better valuation opportunities exist elsewhere. The recent dividend yield of 3.16 per cent lacks appeal.
Mark Elzayed, Vestra Capital
BUY RECOMMENDATIONS
BUY – SKS Technologies Group (SKS)
SKS Technologies has established a significant market footprint in electrical, fibre optic and audiovisual integration for major data centre projects. The company generated revenue of $347.93 million in full year 2026, up 33 per cent on the prior corresponding period. Net profit after tax of $27.11 million surged 93.2 per cent. Data centre revenue of $207.7 million was up 47.6 per cent year on year. The balance sheet is also stronger, with cash from operations increasing 30.5 per cent. The primary catalyst for SKS is its accelerating work on hand and structural exposure to Australia’s expanding data centre market. In my view, SKS represents a high conviction growth opportunity, supported by strong demand visibility and a substantial project pipeline.
BUY – Dicker Data (DDR)
This technology company distributes hardware and software solutions. It benefits from enterprise spending on AI capable servers, network upgrades and end point security hardware. It generated gross revenue of $2.1 billion in the first half of 2026, up 14.2 per cent on the prior corresponding period. Net profit after tax of $60.7 million was up 54.1 per cent. Management has upgraded full year gross revenue guidance to between $4.3 billion and $4.4 billion, alongside profit before tax guidance of between $162 million and $165 million. Double digit top line momentum, an appealing dividend yield and increasing exposure to AI infrastructure spending provides a bright outlook, in my view.
HOLD RECOMMENDATIONS
HOLD – Codan (CDA)
Codan’s technologies include metal detection and communication. Its products are sold in more than 150 countries. Geopolitical instability and rising global defence budgets have created strong secular tailwinds for battlefield tactical communications and defence systems. Codan capitalised on these conditions in fiscal year 2026. It delivered full year group revenue of $875 million, up 30 per cent on the prior corresponding period. Earnings before interest and tax of $244.1 million was up 67 per cent. The company is targeting revenue growth of about 20 per cent in full year 2027, so the short to medium term outlook remains solid. However, after a substantial share price rise, the risk reward balance appears less compelling for new investors.
HOLD – Ansell (ANN)
Ansell makes personal protection equipment for health care and industrial workplaces. It posted global sales of $US2.14 billion in full year year 2026, up 5 per cent on an organic constant currency basis. Adjusted earnings per share of $US1.486 were up 18.5 per cent, while operating cash flow more than doubled to $US270.1 million. Ansell remains a defensive compounder with strong cash generation and improving margins, making it a reliable hold for investors seeking income and stability rather than aggressive earnings growth.
SELL RECOMMENDATIONS
SELL – Select Harvests (SHV)
Select Harvests is a significant global almond producer. Risks include its exposure to seasonal weather volatility and intense international competition, particularly from large US and Californian almond producers. Earnings remain exposed to agricultural yields, almond pricing and input cost volatility. Given the stock’s relatively modest performance compared with higher growth industrial and technology opportunities, the risk-reward profile isn’t as attractive. We would be inclined to cash in some gains after a solid share price performance since mid May.
SELL – Fletcher Building (FBU)
The return to profitability reflected a combination of cost reductions, portfolio simplification, property sale gains and an improved performance across several core manufacturing businesses, rather than a broad based recovery in underlying construction demand. Revenue of $NZ5.994 billion from continuing operations increased 7.3 per cent in full year 2026 when compared to the prior corresponding period. Total net earnings attributable to shareholders reached $NZ228 million, compared to a loss of $NZ419 million in the prior year. The return to profitability improves the balance sheet and reduces financial risk. But, in my view, a continuing recovery remains heavily dependent on building markets returning to normal in what I consider a most challenging underlying environment.
Blake Halligan, Gray Perry Wealth Advisers
BUY RECOMMENDATIONS
BUY – Seek (SEK)
Seek operates a leading online employment marketplace, with a dominant position in Australia and established operations across Asia. Its scalable model, strong margins and international expansion provide attractive long-term growth potential. Despite softer job-ad volumes, fiscal year 2026 net revenue rose 10 per cent and EBITDA increased 15 per cent, demonstrating pricing power and operational resilience. We’re forecasting earnings to grow about 9.5 per cent annually in the next two years. An improving return on equity and a healthy dividend further support the investment case.
BUY – Barrow Hanley Global Share Active ETF (GLOB)
Many investors hold portfolios heavily weighted to listed Australian companies, creating concentration in a relatively small market and narrow range of sectors. GLOB provides diversification through global equities and follows a value approach, seeking companies trading below assessed fair value. The portfolio invests in quality global shares in defensive sectors, which can more than offset cyclical holdings and provide resilience during a broader market pullback. Its focus on valuation and downside risk may complement other Australian equities exposure.
HOLD RECOMMENDATIONS
HOLD – BHP Group (BHP)
BHP remains a high quality diversified miner with large, low cost assets and increasing exposure to copper. The company’s fiscal year 2026 result was strong, with it generating attributable profit of $US9.8 billion, up 9 per cent on the prior corresponding period. Revenue of $US58.8 billion was up 15 per cent. Rising copper demand from electrification and data centres support the longer term outlook, while iron ore operations remain highly competitive. Commodity-price sensitivity and project execution risks support retaining BHP rather than increasing exposure.
HOLD – Xero (XRO)
Xero remains a leading cloud accounting platform, with a dominant position in Australia and New Zealand. Fiscal year 2026 operating revenue increased 31 per cent, supported by 506,000 net customer additions and the Melio Payments acquisition. Melio should aid in revenue growth, but costs associated with its integration contributed to a 27 per cent fall in net profit after tax and a gross margin decline from 89 per cent to 83.9 per cent. The profitable ANZ and UK businesses offer growth potential and could assist in a continuing share price recovery.
SELL RECOMMENDATIONS
SELL – South32 (S32)
South32 is a diversified miner with exposure to copper, aluminium, manganese, zinc, silver and lead. Stronger commodity prices amid announcing the sale of its aluminium value chain assets to Alcoa for up to $US5.6 billion contributed to an increasing share price. Revenue rose 1 per cent in fiscal year 2026 when compared to the prior corresponding period. Underlying EBITDA grew 28 per cent. The stock has risen from $2.64 on September 5, 2025 to trade at $5.20 on September 3, 2026. Given the big share price increase, commodity price volatility, global uncertainty and execution risk on major projects, investors may want to consider cashing in some gains at this stage of the cycle.
SELL – AMP Ltd (AMP)
This wealth management company’s turnaround has gained momentum, with underlying net profit after tax increasing 33 per cent in the first half of 2026. The simplified business, growing North platform and further capital returns are positives. However, much of this improvement appears reflected in the share price. AMP Bank also faces intense mortgage competition, higher funding costs and investment requirements. The shares have risen from $1.16 on March 12 to trade at $2.475 on September 3. The recent share price strength provides an opportunity to reallocate capital elsewhere, as restructuring and execution risks still remain.
The above recommendations are general advice and don’t take into account any individual’s objectives, financial situation or needs. Investors are advised to seek their own professional advice before investing. Please note that TheBull.com.au simply publishes broker recommendations on this page. The publication of these recommendations does not in any way constitute a recommendation on the part of TheBull.com.au. You should seek professional advice before making any investment decisions.
